Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-7772
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial) ; volume:21 ; number:3 ; day:17 ; month:11 ; year:2015 ; pages:523-530 ; date:6.2016
International journal of clinical oncology ; 21, Heft 3 (17.11.2015), 523-530, 6.2016
- Creator
-
Hasegawa, Seiki
- Contributor
-
Okada, Morihito
Tanaka, Fumihiro
Yamanaka, Takeharu
Soejima, Toshinori
Kamikonya, Norihiko
Tsujimura, Tohru
Fukuoka, Kazuya
Yokoi, Kohei
Nakano, Takashi
SpringerLink (Online service)
- DOI
-
10.1007/s10147-015-0925-1
- URN
-
urn:nbn:de:1111-201606117118
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.03.2025, 9:05 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hasegawa, Seiki
- Okada, Morihito
- Tanaka, Fumihiro
- Yamanaka, Takeharu
- Soejima, Toshinori
- Kamikonya, Norihiko
- Tsujimura, Tohru
- Fukuoka, Kazuya
- Yokoi, Kohei
- Nakano, Takashi
- SpringerLink (Online service)
Other Objects (12)
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Management of malignant pleural mesothelioma – part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Management of malignant pleural mesothelioma – part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Management of malignant pleural mesothelioma – part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma